Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
detroit blog main
detroit top stories
5
×
life sciences
national blog main
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
fda
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
national
bristol-myers squibb
cancer
celgene
drugs
genentech
merck
pfizer
starboard value
4d molecular therapeutics
abbvie
acc
What
approved
5
×
drug
fda
bio
news
roundup
second
therapeutics
time
adu
agency
aimmune
allergy
approval
awarded
beats
bids
biogen
cancer
cholesterol
combo
companies
complicated
deeper
depression
developed
digital
dire
disease
dna
epidemic
esperion
esperion’s
fatty
fingerprint
frenzied
friday
genetic
going
good
Language
unset
Current search:
" detroit top stories "
×
approved
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues